Collegium Pharmaceutical
COLL
24.72
-0.49
-1.94%
Collegium Pharmaceutical
US · COLL
#3535 by market cap
Listed 2015
24.72
-0.49
-1.94%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 6 analysts
Buy
Avg price target 45.50 +84.1%
Price target rangecurrent 24.72
Low28.00
Avg45.50
High60.00
Buy 83%
Hold 17%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-13 | Barclays | -- | Buy | 41.00 |
| 2026-11-06 | Piper Sandler | -- | Hold | 28.00 |
| 2026-11-06 | Truist Financial | -- | Buy | 49.00 |
| 2026-11-06 | H.C. Wainwright | -- | Buy | 60.00 |
| 2026-10-15 | Barclays | -- | Buy | 48.00 |
| 2026-10-09 | Oppenheimer | -- | Buy | 50.00 |
| 2026-09-23 | Oppenheimer | -- | Buy | 50.00 |
| 2026-09-21 | H.C. Wainwright | -- | Buy | 60.00 |
| 2026-09-09 | Truist Financial | -- | Buy | 49.00 |
| 2026-09-09 | Leerink Partners | -- | Buy | 45.00 |
| 2026-08-18 | Barclays | -- | Buy | 48.00 |
| 2026-08-07 | Piper Sandler | -- | Hold | 43.00 |
| 2026-08-07 | H.C. Wainwright | -- | Buy | 60.00 |
| 2026-08-06 | Needham | -- | Buy | 46.00 |
| 2026-07-01 | Barclays | -- | Buy | 56.00 |
| 2026-05-14 | Truist Financial | -- | Buy | -- |
| 2026-05-12 | Needham | -- | Buy | 56.00 |
| 2026-05-12 | Barclays | -- | Buy | 56.00 |
| 2026-05-08 | Truist Financial | -- | Buy | -- |
| 2026-05-08 | H.C. Wainwright | -- | Buy | 60.00 |
| 2026-05-07 | Needham | -- | Buy | 56.00 |
| 2026-04-23 | Piper Sandler | -- | Hold | 44.00 |
| 2026-04-23 | H.C. Wainwright | -- | Buy | 60.00 |
| 2026-04-20 | Piper Sandler | -- | Hold | 44.00 |
| 2026-04-16 | Needham | -- | Buy | 56.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | -- | ±22.34% | +6.29% (in line) |
| 2026/Q2 | 2026-08-06 | -- | ±10.36% | -18.55% (beat) |
| 2026/Q1 | 2026-05-07 | -- | ±18.26% | +7.72% (in line) |
| 2025/Q4 | 2026-02-26 | -- | ±8.80% | -3.34% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±13.21% | +13.42% (beat) |
| 2025/Q2 | 2025-08-07 | -- | ±13.38% | +10.72% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±10.56% | +5.94% (in line) |
| 2024/Q4 | 2025-02-27 | After close | ±16.79% | +2.22% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±9.68% | -7.35% (in line) |
| 2024/Q2 | 2024-08-08 | After close | ±8.73% | +0.51% (in line) |
| 2024/Q1 | 2024-05-09 | After close | ±16.30% | -16.80% (beat) |
| 2023/Q4 | 2024-02-22 | After close | ±13.56% | +10.79% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Collegium Pharmaceutical discussion 0 comments